These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7530921)

  • 1. Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.
    Kim D; Durán WN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H399-403. PubMed ID: 7530921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
    Kim DD; Ramírez MM; Durán WN
    Microvasc Res; 2000 Jan; 59(1):7-13. PubMed ID: 10625566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance and exchange microvessels are modulated by different PAF receptors.
    Tomeo AC; Durán WN
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C.
    Kobayashi I; Kim D; Hobson RW; Durán WN
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1214-20. PubMed ID: 8160825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.
    Kim DD; Kleinman DM; Kanetaka T; Gerritsen ME; Nivaggioli T; Weber D; Durán WN
    Microcirculation; 2010 Feb; 17(2):128-36. PubMed ID: 20163539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.
    Hall JM; Brain SD
    Br J Pharmacol; 1994 Oct; 113(2):522-6. PubMed ID: 7530573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-induced arteriolar dilation after tyrosine kinase and nitric oxide synthase inhibition in hamster cheek pouch microcirculation.
    Bertuglia S; Colantuoni A
    J Vasc Res; 1998; 35(4):250-6. PubMed ID: 9701709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin- and substance P-induced edema formation in the hamster cheek pouch is tyrosine kinase dependent.
    Rubinstein I
    J Appl Physiol (1985); 2007 Jul; 103(1):184-9. PubMed ID: 17431087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors modulate agonist-induced vasodilation in the hamster cheek pouch.
    Ikezaki H; Akhter SR; Hong D; Suzuki H; Gao XP; Rubinstein I
    J Appl Physiol (1985); 2000 Mar; 88(3):857-62. PubMed ID: 10710379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
    Kim D; Durán WT; Daniels AJ; Durán WN
    Microvasc Res; 1997 Mar; 53(2):167-72. PubMed ID: 9143549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
    Dillon PK; Durán WN
    Circ Res; 1988 Apr; 62(4):732-40. PubMed ID: 2450695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    Eur J Pharmacol; 2000 Sep; 404(3):387-94. PubMed ID: 10996604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    J Vasc Res; 2002; 39(3):238-45. PubMed ID: 12097822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C modulates microvascular permeability through nitric oxide synthase.
    Ramírez MM; Kim DD; Durán WN
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1702-5. PubMed ID: 8897966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins.
    Svensjö E; Boschcov P; Ketelhuth DF; Jancar S; Gidlund M
    Inflamm Res; 2003 May; 52(5):215-20. PubMed ID: 12813626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of insulin during ischemia-reperfusion injury in hamster cheek pouch microcirculation.
    Colantuoni A; Lapi D; Paterni M; Marchiafava PL
    J Vasc Res; 2005; 42(1):55-66. PubMed ID: 15637441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.